CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Secretaria da Saúde (São Paulo - Estado). Coordenadoria de Controle de Doenças (CCD). Instituto Adolfo Lutz (IAL) (Institutional affiliation from the last research proposal) Birthplace: Brazil
He graduated in Veterinary Medicine from the Federal University of Uberlândia in 2002, subsequently obtaining a masters degree in 2004 and a Ph.D. in Genetics from the same institution in 2008. He completed a postdoctoral fellowship in Biotechnology at the Instituto de Investigación en Recursos Cinegéticos (IREC) of the Universidad de Castilla-la Mancha, Spain, in 2009, and at the Department of Preventive Veterinary Medicine and Animal Health at the Faculty of Veterinary Medicine and Animal Science of the University of São Paulo in 2012. He completed an MBA in Health Innovation Management at the Butantan Institute in 2016. Currently, he is a Scientific Researcher VI at the Immunology Center of the Adolfo Lutz Institute in São Paulo, where he coordinates the Immunotechnology Laboratory. He is also a Principal Investigator for FAPESP at the Center for Translational Science and Biopharmaceutical Development (CTS). He serves as an advisor in the Interunits Graduate Program in Biotechnology (USP, IPT, and IB) and in the Graduate Program in Clinical Research (FMB/CEVAP/Unesp). He has extensive experience in coordinating research and innovation projects, supported by major national funding agencies such as FAPESP, CNPq, CAPES, and FINEP. Research Productivity Scholarship from CNPq. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The widespread use of bacteriophages over the last hundred years is based on the structural diversity of these viral particles. Different types of bacteriophages participated in innovative studies that allowed the development of new biotechnological techniques. Among them, the phage display technique stands out, which allows the construction of antibodies or peptide libraries generated fr…
IAL has established itself as a reference institution in Public Health, developing scientific research and performing analytical procedures for diagnostic elucidation and sanitary control, rapidly addressing the demands of Health Surveillance of the different regions of the State of Sao Paulo and other units of the federation. The data regarding the IAL scientific-technical production (se…
Given the growing number of diseases caused by emerging or endemic pathogens in Brazil, like Brazilian spotted fever (BSF) is the most important and frequent rickettsia) disease in Brazil, original strategies are urgently required for pathogen characterization: (1) Better understanding of the immune proteome of pathogens, which has been limited because of a lack of detailed knowledge of t…
Antibodies against SAR-CoV-2 are essential for understanding and fighting the COVID-19 pandemic. They perform some functions, such as elimination of the virus from infected patients, reagents for rapid diagnoses, constitute the first line of treatment for hospitalized patients and are the main objective of vaccine development. The vaccines and therapeutic antibodies currently available we…
(Only some records are available in English at this moment)
Most current therapeutic antibodies for COVID-19 were developed to the Spike protein of SARS-CoV-2. However, their effectiveness has been diminished due to antigenic variation, driven mainly by mutations in the receptor-binding domain (RBD) of the Spike protein, highlighting the need of searching for broadly neutralizing antibodies that can target both existing and future variants. In thi…
| 1 / 1 | Ongoing grants |
| 6 / 3 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 6 / 4 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 16 / 11 | All research grants and scholarships |
| Associated processes | |